|
KO |
09100 Metabolism
|
|
|
09120 Genetic Information Processing
|
|
|
09130 Environmental Information Processing
|
|
|
09140 Cellular Processes
|
|
|
09150 Organismal Systems
|
|
|
09151 Immune system
|
04640 Hematopoietic cell lineage [PATH:hsa04640]
|
04610 Complement and coagulation cascades [PATH:hsa04610]
|
04611 Platelet activation [PATH:hsa04611]
|
04613 Neutrophil extracellular trap formation [PATH:hsa04613]
|
04620 Toll-like receptor signaling pathway [PATH:hsa04620]
|
04624 Toll and Imd signaling pathway
|
04621 NOD-like receptor signaling pathway [PATH:hsa04621]
|
10392 NOD1; nucleotide binding oligomerization domain containing 1
8767 RIPK2; receptor interacting serine/threonine kinase 2
8517 IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma
1147 CHUK; component of inhibitor of nuclear factor kappa B kinase complex
3551 IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta
4793 NFKBIB; NFKB inhibitor beta
4792 NFKBIA; NFKB inhibitor alpha
4790 NFKB1; nuclear factor kappa B subunit 1
5970 RELA; RELA proto-oncogene, NF-kB subunit
3553 IL1B; interleukin 1 beta
3606 IL18; interleukin 18
3569 IL6; interleukin 6
7124 TNF; tumor necrosis factor
3576 CXCL8; C-X-C motif chemokine ligand 8
2919 CXCL1; C-X-C motif chemokine ligand 1
2920 CXCL2; C-X-C motif chemokine ligand 2
2921 CXCL3; C-X-C motif chemokine ligand 3
6347 CCL2; C-C motif chemokine ligand 2
6352 CCL5; C-C motif chemokine ligand 5
820 CAMP; cathelicidin antimicrobial peptide
1667 DEFA1; defensin alpha 1
1668 DEFA3; defensin alpha 3
1669 DEFA4; defensin alpha 4
1670 DEFA5; defensin alpha 5
1671 DEFA6; defensin alpha 6
728358 DEFA1B; defensin alpha 1B
1673 DEFB4A; defensin beta 4A
100289462 DEFB4B; defensin beta 4B
414325 DEFB103A; defensin beta 103A
55894 DEFB103B; defensin beta 103B
64127 NOD2; nucleotide binding oligomerization domain containing 2
6885 MAP3K7; mitogen-activated protein kinase kinase kinase 7
10454 TAB1; TGF-beta activated kinase 1 (MAP3K7) binding protein 1
23118 TAB2; TGF-beta activated kinase 1 (MAP3K7) binding protein 2
257397 TAB3; TGF-beta activated kinase 1 (MAP3K7) binding protein 3
5594 MAPK1; mitogen-activated protein kinase 1
5595 MAPK3; mitogen-activated protein kinase 3
5599 MAPK8; mitogen-activated protein kinase 8
5602 MAPK10; mitogen-activated protein kinase 10
5601 MAPK9; mitogen-activated protein kinase 9
5600 MAPK11; mitogen-activated protein kinase 11
6300 MAPK12; mitogen-activated protein kinase 12
5603 MAPK13; mitogen-activated protein kinase 13
1432 MAPK14; mitogen-activated protein kinase 14
3725 JUN; Jun proto-oncogene, AP-1 transcription factor subunit
55054 ATG16L1; autophagy related 16 like 1
9474 ATG5; autophagy related 5
9140 ATG12; autophagy related 12
11337 GABARAP; GABA type A receptor-associated protein
23710 GABARAPL1; GABA type A receptor associated protein like 1
11345 GABARAPL2; GABA type A receptor associated protein like 2
440738 MAP1LC3C; microtubule associated protein 1 light chain 3 gamma
81631 MAP1LC3B; microtubule associated protein 1 light chain 3 beta
84557 MAP1LC3A; microtubule associated protein 1 light chain 3 alpha
643246 MAP1LC3B2; microtubule associated protein 1 light chain 3 beta 2
10910 SUGT1; SGT1 homolog, MIS12 kinetochore complex assembly cochaperone
81858 SHARPIN; SHANK associated RH domain interactor
10616 RBCK1; RANBP2-type and C3HC4-type zinc finger containing 1
55072 RNF31; ring finger protein 31
331 XIAP; X-linked inhibitor of apoptosis
84674 CARD6; caspase recruitment domain family member 6
7205 TRIP6; thyroid hormone receptor interactor 6
55914 ERBIN; erbb2 interacting protein
329 BIRC2; baculoviral IAP repeat containing 2
330 BIRC3; baculoviral IAP repeat containing 3
7186 TRAF2; TNF receptor associated factor 2
7188 TRAF5; TNF receptor associated factor 5
7189 TRAF6; TNF receptor associated factor 6
64170 CARD9; caspase recruitment domain family member 9
7128 TNFAIP3; TNF alpha induced protein 3
57506 MAVS; mitochondrial antiviral signaling protein
7187 TRAF3; TNF receptor associated factor 3
29110 TBK1; TANK binding kinase 1
9641 IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon
10010 TANK; TRAF family member associated NFKB activator
3661 IRF3; interferon regulatory factor 3
3665 IRF7; interferon regulatory factor 7
3439 IFNA1; interferon alpha 1
3440 IFNA2; interferon alpha 2
3441 IFNA4; interferon alpha 4
3442 IFNA5; interferon alpha 5
3443 IFNA6; interferon alpha 6
3444 IFNA7; interferon alpha 7
3445 IFNA8; interferon alpha 8
3446 IFNA10; interferon alpha 10
3447 IFNA13; interferon alpha 13
3448 IFNA14; interferon alpha 14
3449 IFNA16; interferon alpha 16
3451 IFNA17; interferon alpha 17
3452 IFNA21; interferon alpha 21
3456 IFNB1; interferon beta 1
79671 NLRX1; NLR family member X1
118429 ANTXR2; ANTXR cell adhesion molecule 2
84168 ANTXR1; ANTXR cell adhesion molecule 1
22861 NLRP1; NLR family pyrin domain containing 1
29108 PYCARD; PYD and CARD domain containing
834 CASP1; caspase 1
596 BCL2; BCL2 apoptosis regulator
598 BCL2L1; BCL2 like 1
1508 CTSB; cathepsin B
114548 NLRP3; NLR family pyrin domain containing 3
24145 PANX1; pannexin 1
5027 P2RX7; purinergic receptor P2X 7
7226 TRPM2; transient receptor potential cation channel subfamily M member 2
54822 TRPM7; transient receptor potential cation channel subfamily M member 7
51393 TRPV2; transient receptor potential cation channel subfamily V member 2
846 CASR; calcium sensing receptor
222545 GPRC6A; G protein-coupled receptor class C group 6 member A
23236 PLCB1; phospholipase C beta 1
5330 PLCB2; phospholipase C beta 2
5331 PLCB3; phospholipase C beta 3
5332 PLCB4; phospholipase C beta 4
3708 ITPR1; inositol 1,4,5-trisphosphate receptor type 1
3709 ITPR2; inositol 1,4,5-trisphosphate receptor type 2
3710 ITPR3; inositol 1,4,5-trisphosphate receptor type 3
7416 VDAC1; voltage dependent anion channel 1
7417 VDAC2; voltage dependent anion channel 2
7419 VDAC3; voltage dependent anion channel 3
90550 MCU; mitochondrial calcium uniporter
4938 OAS1; 2'-5'-oligoadenylate synthetase 1
4939 OAS2; 2'-5'-oligoadenylate synthetase 2
4940 OAS3; 2'-5'-oligoadenylate synthetase 3
6041 RNASEL; ribonuclease L
56919 DHX33; DEAH-box helicase 33
55669 MFN1; mitofusin 1
9927 MFN2; mitofusin 2
8737 RIPK1; receptor interacting serine/threonine kinase 1
11035 RIPK3; receptor interacting serine/threonine kinase 3
10059 DNM1L; dynamin 1 like
10135 NAMPT; nicotinamide phosphoribosyltransferase
1536 CYBB; cytochrome b-245 beta chain
1535 CYBA; cytochrome b-245 alpha chain
10628 TXNIP; thioredoxin interacting protein
7295 TXN; thioredoxin
25828 TXN2; thioredoxin 2
140609 NEK7; NIMA related kinase 7
79184 BRCC3; BRCA1/BRCA2-containing complex subunit 3
3320 HSP90AA1; heat shock protein 90 alpha family class A member 1
3326 HSP90AB1; heat shock protein 90 alpha family class B member 1
22900 CARD8; caspase recruitment domain family member 8
63940 GPSM3; G protein signaling modulator 3
345611 IRGM; immunity related GTPase M
260434 PYDC1; pyrin domain containing 1
152138 PYDC2; pyrin domain containing 2
4210 MEFV; MEFV innate immunity regulator, pyrin
9051 PSTPIP1; proline-serine-threonine phosphatase interacting protein 1
841 CASP8; caspase 8
8772 FADD; Fas associated via death domain
100506742 CASP12; caspase 12 (gene/pseudogene)
59082 CARD18; caspase recruitment domain family member 18
114769 CARD16; caspase recruitment domain family member 16
171389 NLRP6; NLR family pyrin domain containing 6
199713 NLRP7; NLR family pyrin domain containing 7
91662 NLRP12; NLR family pyrin domain containing 12
4671 NAIP; NLR family apoptosis inhibitory protein
58484 NLRC4; NLR family CARD domain containing 4
5580 PRKCD; protein kinase C delta
2634 GBP2; guanylate binding protein 2
115362 GBP5; guanylate binding protein 5
9447 AIM2; absent in melanoma 2
3428 IFI16; interferon gamma inducible protein 16
7158 TP53BP1; tumor protein p53 binding protein 1
107181291 PYDC5; pyrin domain containing 5
387 RHOA; ras homolog family member A
5585 PKN1; protein kinase N1
5586 PKN2; protein kinase N2
7531 YWHAE; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon
2633 GBP1; guanylate binding protein 1
2635 GBP3; guanylate binding protein 3
115361 GBP4; guanylate binding protein 4
388646 GBP7; guanylate binding protein 7
838 CASP5; caspase 5
837 CASP4; caspase 4
79792 GSDMD; gasdermin D
3454 IFNAR1; interferon alpha and beta receptor subunit 1
3455 IFNAR2; interferon alpha and beta receptor subunit 2
3716 JAK1; Janus kinase 1
7297 TYK2; tyrosine kinase 2
6772 STAT1; signal transducer and activator of transcription 1
6773 STAT2; signal transducer and activator of transcription 2
10379 IRF9; interferon regulatory factor 9
7099 TLR4; toll like receptor 4
148022 TICAM1; TIR domain containing adaptor molecule 1
4615 MYD88; MYD88 innate immune signal transduction adaptor
51135 IRAK4; interleukin 1 receptor associated kinase 4
340061 STING1; stimulator of interferon response cGAMP interactor 1
|
K08727 NOD1; nucleotide-binding oligomerization domain-containing protein 1
K08846 RIPK2; receptor-interacting serine/threonine-protein kinase 2 [EC:2.7.11.1]
K07210 IKBKG; inhibitor of nuclear factor kappa-B kinase subunit gamma
K04467 IKBKA; inhibitor of nuclear factor kappa-B kinase subunit alpha [EC:2.7.11.10]
K07209 IKBKB; inhibitor of nuclear factor kappa-B kinase subunit beta [EC:2.7.11.10]
K02581 NFKBIB; NF-kappa-B inhibitor beta
K04734 NFKBIA; NF-kappa-B inhibitor alpha
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K04519 IL1B; interleukin 1 beta
K05482 IL18; interleukin 18
K05405 IL6; interleukin 6
K03156 TNF; tumor necrosis factor superfamily, member 2
K10030 IL8; interleukin 8
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K05505 CXCL1_2_3; C-X-C motif chemokine 1/2/3
K14624 CCL2; C-C motif chemokine 2
K12499 CCL5; C-C motif chemokine 5
K13916 CAMP; cathelicidin antimicrobial peptide
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K21100 DEFB4; beta-defensin 4
K21100 DEFB4; beta-defensin 4
K23126 DEFB103; beta-defensin 103
K23126 DEFB103; beta-defensin 103
K10165 NOD2; nucleotide-binding oligomerization domain-containing protein 2
K04427 MAP3K7; mitogen-activated protein kinase kinase kinase 7 [EC:2.7.11.25]
K04403 MAP3K7IP1; TAK1-binding protein 1
K04404 MAP3K7IP2; TAK1-binding protein 2
K12793 MAP3K7IP3; TAK1-binding protein 3
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04371 ERK; mitogen-activated protein kinase 1/3 [EC:2.7.11.24]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04440 JNK; mitogen-activated protein kinase 8/9/10 (c-Jun N-terminal kinase) [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04441 P38; p38 MAP kinase [EC:2.7.11.24]
K04448 JUN; transcription factor AP-1
K17890 ATG16L1; autophagy-related protein 16-1
K08339 ATG5; autophagy-related protein 5
K08336 ATG12; ubiquitin-like protein ATG12
K08341 GABARAP; GABA(A) receptor-associated protein
K08341 GABARAP; GABA(A) receptor-associated protein
K08341 GABARAP; GABA(A) receptor-associated protein
K10435 MAP1LC; microtubule-associated protein 1 light chain
K10435 MAP1LC; microtubule-associated protein 1 light chain
K10435 MAP1LC; microtubule-associated protein 1 light chain
K10435 MAP1LC; microtubule-associated protein 1 light chain
K12795 SUGT1; suppressor of G2 allele of SKP1
K20894 SHARPIN; shank-associated RH domain-interacting protein
K10630 RBCK1; RanBP-type and C3HC4-type zinc finger-containing protein 1 [EC:2.3.2.31]
K11974 RNF31; E3 ubiquitin-protein ligase RNF31 [EC:2.3.2.31]
K04725 XIAP; E3 ubiquitin-protein ligase XIAP [EC:2.3.2.27]
K12797 CARD6; caspase recruitment domain-containing protein 6
K12792 TRIP6; thyroid receptor-interacting protein 6
K12796 ERBIN; erbb2-interacting protein
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K03173 TRAF2; TNF receptor-associated factor 2 [EC:2.3.2.27]
K09849 TRAF5; TNF receptor-associated factor 5
K03175 TRAF6; TNF receptor-associated factor 6 [EC:2.3.2.27]
K12794 CARD9; caspase recruitment domain-containing protein 9
K11859 TNFAIP3; tumor necrosis factor, alpha-induced protein 3 [EC:3.4.19.12]
K12648 MAVS; mitochondrial antiviral-signaling protein
K03174 TRAF3; TNF receptor-associated factor 3
K05410 TBK1; TANK-binding kinase 1 [EC:2.7.11.10]
K07211 IKBKE; inhibitor of nuclear factor kappa-B kinase subunit epsilon [EC:2.7.11.10]
K12650 TANK; TRAF family member-associated NF-kappa-B activator
K05411 IRF3; interferon regulatory factor 3
K09447 IRF7; interferon regulatory factor 7
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05414 IFNA; interferon alpha
K05415 IFNB; interferon beta
K12653 NLRX1; NLR family member X1
K20909 ANTXR; anthrax toxin receptor
K20909 ANTXR; anthrax toxin receptor
K12798 NLRP1; NACHT, LRR and PYD domains-containing protein 1
K12799 PYCARD; apoptosis-associated speck-like protein containing a CARD
K01370 CASP1; caspase 1 [EC:3.4.22.36]
K02161 BCL2; apoptosis regulator Bcl-2
K04570 BCL2L1; Bcl-2-like 1 (apoptosis regulator Bcl-X)
K01363 CTSB; cathepsin B [EC:3.4.22.1]
K12800 NLRP3; NACHT, LRR and PYD domains-containing protein 3
K03443 PANX1; pannexin 1
K05220 P2RX7; P2X purinoceptor 7
K04977 TRPM2; transient receptor potential cation channel subfamily M member 2 [EC:3.6.1.13]
K04982 TRPM7; transient receptor potential cation channel subfamily M member 7 [EC:2.7.11.1]
K04971 TRPV2; transient receptor potential cation channel subfamily V member 2
K04612 CASR; calcium-sensing receptor
K04622 GPRC6A; G protein-coupled receptor family C group 6 member A
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K05858 PLCB; phosphatidylinositol phospholipase C, beta [EC:3.1.4.11]
K04958 ITPR1; inositol 1,4,5-triphosphate receptor type 1
K04959 ITPR2; inositol 1,4,5-triphosphate receptor type 2
K04960 ITPR3; inositol 1,4,5-triphosphate receptor type 3
K05862 VDAC1; voltage-dependent anion channel protein 1
K15040 VDAC2; voltage-dependent anion channel protein 2
K15041 VDAC3; voltage-dependent anion channel protein 3
K20858 MCU; calcium uniporter protein, mitochondrial
K14216 OAS; 2'-5'-oligoadenylate synthetase [EC:2.7.7.84]
K14216 OAS; 2'-5'-oligoadenylate synthetase [EC:2.7.7.84]
K14216 OAS; 2'-5'-oligoadenylate synthetase [EC:2.7.7.84]
K01165 RNASEL; ribonuclease L
K17820 DHX33; ATP-dependent RNA helicase DHX33 [EC:5.6.2.6]
K21356 MFN1; mitofusin 1 [EC:3.6.5.-]
K06030 MFN2; mitofusin 2 [EC:3.6.5.-]
K02861 RIPK1; receptor-interacting serine/threonine-protein kinase 1 [EC:2.7.11.1]
K08847 RIPK3; receptor-interacting serine/threonine-protein kinase 3 [EC:2.7.11.1]
K17065 DNM1L; dynamin 1-like protein [EC:3.6.5.5]
K03462 NAMPT; nicotinamide phosphoribosyltransferase [EC:2.4.2.12]
K21421 NOX2; NADPH oxidase 2 [EC:1.-.-.-]
K08009 CYBA; cytochrome b-245, alpha polypeptide
K20910 TXNIP; thioredoxin-interacting protein
K03671 TXN; thioredoxin
K03671 TXN; thioredoxin
K20876 NEK7; serine/threonine-protein kinase Nek7 [EC:2.7.11.34]
K11864 BRCC3; BRCA1/BRCA2-containing complex subunit 3 [EC:3.4.19.-]
K04079 HSP90A; molecular chaperone HtpG
K04079 HSP90A; molecular chaperone HtpG
K12801 CARD8; caspase recruitment domain-containing protein 8
K15838 GPSM3; G-protein signaling modulator 3
K14139 IRGM; immunity-related GTPase family M protein [EC:3.6.5.-]
K12802 PYDC1; pyrin domain-containing protein 1
K20911 PYDC2; pyrin domain-containing protein 2
K12803 MEFV; pyrin
K12804 PSTPIP1; proline-serine-threonine phosphatase interacting protein 1
K04398 CASP8; caspase 8 [EC:3.4.22.61]
K02373 FADD; FAS-associated death domain protein
K04741 CASP12; caspase 12 [EC:3.4.22.-]
K12806 CARD16_17_18; caspase recruitment domain-containing protein 16/17/18
K12806 CARD16_17_18; caspase recruitment domain-containing protein 16/17/18
K20863 NLRP6; NACHT, LRR and PYD domains-containing protein 6
K20864 NLRP7; NACHT, LRR and PYD domains-containing protein 7
K20865 NLRP12; NACHT, LRR and PYD domains-containing protein 12
K12807 NAIP; baculoviral IAP repeat-containing protein 1
K12805 NLRC4; NLR family CARD domain-containing protein 4
K06068 PRKCD; novel protein kinase C delta type [EC:2.7.11.13]
K20897 GBP2; guanylate-binding protein 2
K20898 GBP5; guanylate-binding protein 5
K12966 AIM2; absent in melanoma 2
K20914 IFI16; gamma-interferon-inducible protein 16
K20915 TP53BP1; tumor suppressor p53-binding protein 1
K20916 POP3; pyrin domain-only protein 3
K04513 RHOA; Ras homolog gene family, member A
K06071 PKN1; serine/threonine-protein kinase N1 [EC:2.7.11.13]
K23691 PKN2; serine/threonine-protein kinase N2 [EC:2.7.11.13]
K06630 YWHAE; 14-3-3 protein epsilon
K20899 GBP1_3_4_7; guanylate-binding protein 1/3/4/7
K20899 GBP1_3_4_7; guanylate-binding protein 1/3/4/7
K20899 GBP1_3_4_7; guanylate-binding protein 1/3/4/7
K20899 GBP1_3_4_7; guanylate-binding protein 1/3/4/7
K04395 CASP5; caspase 5 [EC:3.4.22.58]
K04394 CASP4; caspase 4 [EC:3.4.22.57 3.4.22.64]
K20917 GSDMD; gasdermin-D
K05130 IFNAR1; interferon receptor 1
K05131 IFNAR2; interferon receptor 2
K11217 JAK1; Janus kinase 1 [EC:2.7.10.2]
K11219 TYK2; non-receptor tyrosine-protein kinase TYK2 [EC:2.7.10.2]
K11220 STAT1; signal transducer and activator of transcription 1
K11221 STAT2; signal transducer and activator of transcription 2
K04693 IRF9; interferon regulatory factor 9
K10160 TLR4; toll-like receptor 4
K05842 TRIF; toll-like receptor adapter molecule 1
K04729 MYD88; myeloid differentiation primary response protein MyD88
K04733 IRAK4; interleukin-1 receptor-associated kinase 4 [EC:2.7.11.1]
K12654 STING1; stimulator of interferon genes protein
|
04622 RIG-I-like receptor signaling pathway [PATH:hsa04622]
|
04623 Cytosolic DNA-sensing pathway [PATH:hsa04623]
|
04625 C-type lectin receptor signaling pathway [PATH:hsa04625]
|
04650 Natural killer cell mediated cytotoxicity [PATH:hsa04650]
|
04612 Antigen processing and presentation [PATH:hsa04612]
|
04660 T cell receptor signaling pathway [PATH:hsa04660]
|
04658 Th1 and Th2 cell differentiation [PATH:hsa04658]
|
04659 Th17 cell differentiation [PATH:hsa04659]
|
04657 IL-17 signaling pathway [PATH:hsa04657]
|
04662 B cell receptor signaling pathway [PATH:hsa04662]
|
04664 Fc epsilon RI signaling pathway [PATH:hsa04664]
|
04666 Fc gamma R-mediated phagocytosis [PATH:hsa04666]
|
04670 Leukocyte transendothelial migration [PATH:hsa04670]
|
04672 Intestinal immune network for IgA production [PATH:hsa04672]
|
04062 Chemokine signaling pathway [PATH:hsa04062]
|
|
|
09152 Endocrine system
|
|
|
09153 Circulatory system
|
|
|
09154 Digestive system
|
|
|
09155 Excretory system
|
|
|
09156 Nervous system
|
|
|
09157 Sensory system
|
|
|
09158 Development and regeneration
|
|
|
09149 Aging
|
|
|
09159 Environmental adaptation
|
|
|
09160 Human Diseases
|
|
|
09161 Cancer: overview
|
05200 Pathways in cancer [PATH:hsa05200]
|
05202 Transcriptional misregulation in cancer [PATH:hsa05202]
|
861 RUNX1; RUNX family transcription factor 1
1436 CSF1R; colony stimulating factor 1 receptor
4353 MPO; myeloperoxidase
1437 CSF2; colony stimulating factor 2
3562 IL3; interleukin 3
862 RUNX1T1; RUNX1 partner transcriptional co-repressor 1
3065 HDAC1; histone deacetylase 1
3066 HDAC2; histone deacetylase 2
25942 SIN3A; SIN3 transcription regulator family member A
9611 NCOR1; nuclear receptor corepressor 1
1050 CEBPA; CCAAT enhancer binding protein alpha
8864 PER2; period circadian regulator 2
6688 SPI1; Spi-1 proto-oncogene
929 CD14; CD14 molecule
3684 ITGAM; integrin subunit alpha M
2209 FCGR1A; Fc gamma receptor Ia
3728 JUP; junction plakoglobin
5371 PML; PML nuclear body scaffold
5914 RARA; retinoic acid receptor alpha
890 CCNA2; cyclin A2
8900 CCNA1; cyclin A1
1053 CEBPE; CCAAT enhancer binding protein epsilon
597 BCL2A1; BCL2 related protein A1
7704 ZBTB16; zinc finger and BTB domain containing 16
4609 MYC; MYC proto-oncogene, bHLH transcription factor
1848 DUSP6; dual specificity phosphatase 6
6929 TCF3; transcription factor 3
5087 PBX1; PBX homeobox 1
51384 WNT16; Wnt family member 16
2120 ETV6; ETS variant transcription factor 6
51513 ETV7; ETS variant transcription factor 7
1667 DEFA1; defensin alpha 1
1668 DEFA3; defensin alpha 3
1669 DEFA4; defensin alpha 4
1670 DEFA5; defensin alpha 5
1671 DEFA6; defensin alpha 6
728358 DEFA1B; defensin alpha 1B
1991 ELANE; elastase, neutrophil expressed
3002 GZMB; granzyme B
4297 KMT2A; lysine methyltransferase 2A
4299 AFF1; ALF transcription elongation factor 1
1025 CDK9; cyclin dependent kinase 9
904 CCNT1; cyclin T1
905 CCNT2; cyclin T2
4298 MLLT1; MLLT1 super elongation complex subunit
4300 MLLT3; MLLT3 super elongation complex subunit
84444 DOT1L; DOT1 like histone lysine methyltransferase
4005 LMO2; LIM domain only 2
5090 PBX3; PBX homeobox 3
860 RUNX2; RUNX family transcription factor 2
4086 SMAD1; SMAD family member 1
51274 KLF3; KLF transcription factor 3
4208 MEF2C; myocyte enhancer factor 2C
3205 HOXA9; homeobox A9
3206 HOXA10; homeobox A10
221037 JMJD1C; jumonji domain containing 1C
8091 HMGA2; high mobility group AT-hook 2
7403 KDM6A; lysine demethylase 6A
8464 SUPT3H; SPT3 homolog, SAGA and STAGA complex component
8842 PROM1; prominin 1
2322 FLT3; fms related receptor tyrosine kinase 3
55589 BMP2K; BMP2 inducible kinase
3480 IGF1R; insulin like growth factor 1 receptor
1027 CDKN1B; cyclin dependent kinase inhibitor 1B
5218 CDK14; cyclin dependent kinase 14
4211 MEIS1; Meis homeobox 1
3207 HOXA11; homeobox A11
6495 SIX1; SIX homeobox 1
51804 SIX4; SIX homeobox 4
2138 EYA1; EYA transcriptional coactivator and phosphatase 1
1031 CDKN2C; cyclin dependent kinase inhibitor 2C
3248 HPGD; 15-hydroxyprostaglandin dehydrogenase
2892 GRIA3; glutamate ionotropic receptor AMPA type subunit 3
2530 FUT8; fucosyltransferase 8
30012 TLX3; T cell leukemia homeobox 3
3195 TLX1; T cell leukemia homeobox 1
64919 BCL11B; BCL11 transcription factor B
8861 LDB1; LIM domain binding 1
4066 LYL1; LYL1 basic helix-loop-helix family member
3087 HHEX; hematopoietically expressed homeobox
171558 PTCRA; pre T cell antigen receptor alpha
5966 REL; REL proto-oncogene, NF-kB subunit
894 CCND2; cyclin D2
329 BIRC2; baculoviral IAP repeat containing 2
330 BIRC3; baculoviral IAP repeat containing 3
7185 TRAF1; TNF receptor associated factor 1
598 BCL2L1; BCL2 like 1
942 CD86; CD86 molecule
958 CD40; CD40 molecule
604 BCL6; BCL6 transcription repressor
102723407 IGH; immunoglobulin heavy variable 4-38-2-like
4094 MAF; MAF bZIP transcription factor
3695 ITGB7; integrin subunit beta 7
7468 NSD2; nuclear receptor binding SET domain protein 2
440093 H3-5; H3.5 histone
3021 H3-3B; H3.3 histone B
8351 H3C4; H3 clustered histone 4
8352 H3C3; H3 clustered histone 3
8350 H3C1; H3 clustered histone 1
3020 H3-3A; H3.3 histone A
8290 H3-4; H3.4 histone, cluster member
126961 H3C14; H3 clustered histone 14
333932 H3C15; H3 clustered histone 15
653604 H3C13; H3 clustered histone 13
8353 H3C6; H3 clustered histone 6
8354 H3C11; H3 clustered histone 11
8355 H3C8; H3 clustered histone 8
8356 H3C12; H3 clustered histone 12
8357 H3C10; H3 clustered histone 10
8358 H3C2; H3 clustered histone 2
8968 H3C7; H3 clustered histone 7
5079 PAX5; paired box 5
7849 PAX8; paired box 8
5468 PPARG; peroxisome proliferator activated receptor gamma
6256 RXRA; retinoid X receptor alpha
6257 RXRB; retinoid X receptor beta
6258 RXRG; retinoid X receptor gamma
5546 PRCC; proline rich mitotic checkpoint control factor
7030 TFE3; transcription factor binding to IGHM enhancer 3
1026 CDKN1A; cyclin dependent kinase inhibitor 1A
7113 TMPRSS2; transmembrane serine protease 2
2078 ERG; ETS transcription factor ERG
5328 PLAU; plasminogen activator, urokinase
5327 PLAT; plasminogen activator, tissue type
4314 MMP3; matrix metallopeptidase 3
4318 MMP9; matrix metallopeptidase 9
6935 ZEB1; zinc finger E-box binding homeobox 1
7850 IL1R2; interleukin 1 receptor type 2
6692 SPINT1; serine peptidase inhibitor, Kunitz type 1
2115 ETV1; ETS variant transcription factor 1
2118 ETV4; ETS variant transcription factor 4
2119 ETV5; ETS variant transcription factor 5
85414 SLC45A3; solute carrier family 45 member 3
2005 ELK4; ETS transcription factor ELK4
1655 DDX5; DEAD-box helicase 5
4613 MYCN; MYCN proto-oncogene, bHLH transcription factor
4149 MAX; MYC associated factor X
4193 MDM2; MDM2 proto-oncogene
5747 PTK2; protein tyrosine kinase 2
7157 TP53; tumor protein p53
648 BMI1; BMI1 proto-oncogene, polycomb ring finger
100532731 COMMD3-BMI1; COMMD3-BMI1 readthrough
6667 SP1; Sp1 transcription factor
7709 ZBTB17; zinc finger and BTB domain containing 17
4914 NTRK1; neurotrophic receptor tyrosine kinase 1
4804 NGFR; nerve growth factor receptor
4221 MEN1; menin 1
2130 EWSR1; EWS RNA binding protein 1
2313 FLI1; Fli-1 proto-oncogene, ETS transcription factor
3479 IGF1; insulin like growth factor 1
3398 ID2; inhibitor of DNA binding 2
7048 TGFBR2; transforming growth factor beta receptor 2
3486 IGFBP3; insulin like growth factor binding protein 3
54738 FEV; FEV transcription factor, ETS family member
466 ATF1; activating transcription factor 1
9915 ARNT2; aryl hydrocarbon receptor nuclear translocator 2
472 ATM; ATM serine/threonine kinase
4286 MITF; melanocyte inducing transcription factor
7490 WT1; WT1 transcription factor
5154 PDGFA; platelet derived growth factor subunit A
3560 IL2RB; interleukin 2 receptor subunit beta
8938 BAIAP3; BAI1 associated protein 3
7102 TSPAN7; tetraspanin 7
4291 MLF1; myeloid leukemia factor 1
8013 NR4A3; nuclear receptor subfamily 4 group A member 3
8148 TAF15; TATA-box binding protein associated factor 15
2521 FUS; FUS RNA binding protein
1649 DDIT3; DNA damage inducible transcript 3
1051 CEBPB; CCAAT enhancer binding protein beta
3569 IL6; interleukin 6
64332 NFKBIZ; NFKB inhibitor zeta
4790 NFKB1; nuclear factor kappa B subunit 1
5970 RELA; RELA proto-oncogene, NF-kB subunit
3576 CXCL8; C-X-C motif chemokine ligand 8
5081 PAX7; paired box 7
5077 PAX3; paired box 3
2308 FOXO1; forkhead box O1
2321 FLT1; fms related receptor tyrosine kinase 1
26039 SS18L1; SS18L1 subunit of BAF chromatin remodeling complex
6760 SS18; SS18 subunit of BAF chromatin remodeling complex
6756 SSX1; SSX family member 1
6757 SSX2; SSX family member 2
727837 SSX2B; SSX family member 2B
26471 NUPR1; nuclear protein 1, transcriptional regulator
79058 ASPSCR1; ASPSCR1 tether for SLC2A4, UBX domain containing
4233 MET; MET proto-oncogene, receptor tyrosine kinase
1647 GADD45A; growth arrest and DNA damage inducible alpha
4616 GADD45B; growth arrest and DNA damage inducible beta
10912 GADD45G; growth arrest and DNA damage inducible gamma
581 BAX; BCL2 associated X, apoptosis regulator
578 BAK1; BCL2 antagonist/killer 1
1643 DDB2; damage specific DNA binding protein 2
51426 POLK; DNA polymerase kappa
|
K08367 RUNX1; runt-related transcription factor 1
K05090 CSF1R; macrophage colony-stimulating factor 1 receptor [EC:2.7.10.1]
K10789 MPO; myeloperoxidase [EC:1.11.2.2]
K05427 CSF2; granulocyte-macrophage colony-stimulating factor
K04736 IL3; interleukin 3
K10053 RUNX1T1; CBFA2/RNUX1 translocation partner 1
K06067 HDAC1_2; histone deacetylase 1/2 [EC:3.5.1.98]
K06067 HDAC1_2; histone deacetylase 1/2 [EC:3.5.1.98]
K11644 SIN3A; paired amphipathic helix protein Sin3a
K04650 NCOR1; nuclear receptor co-repressor 1
K09055 CEBPA; CCAAT/enhancer binding protein (C/EBP), alpha
K02633 PER2; period circadian protein 2
K09438 SPI1; transcription factor PU.1
K04391 CD14; monocyte differentiation antigen CD14
K06461 ITGAM; integrin alpha M
K06498 FCGR1A; high affinity immunoglobulin gamma Fc receptor I
K10056 JUP; junction plakoglobin
K10054 PML; E3 SUMO-protein ligase PML [EC:2.3.2.-]
K08527 RARA; retinoic acid receptor alpha
K06627 CCNA; cyclin-A
K06627 CCNA; cyclin-A
K10051 CEBPE; CCAAT/enhancer binding protein (C/EBP), epsilon
K02162 BCL2A1; hematopoietic Bcl-2-related protein A1
K10055 ZBTB16; zinc finger and BTB domain-containing protein 16
K04377 MYC; Myc proto-oncogene protein
K21946 DUSP6; dual specificity phosphatase 6 [EC:3.1.3.16 3.1.3.48]
K09063 TCF3; transcription factor E2-alpha
K09355 PBX1; pre-B-cell leukemia transcription factor 1
K01558 WNT16; wingless-type MMTV integration site family, member 16
K03211 ETV6_7; ETS translocation variant 6/7
K03211 ETV6_7; ETS translocation variant 6/7
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K01327 ELANE; leukocyte elastase [EC:3.4.21.37]
K01353 GZMB; granzyme B [EC:3.4.21.79]
K09186 MLL1; [histone H3]-lysine4 N-trimethyltransferase MLL1 [EC:2.1.1.354]
K15184 AFF1; AF4/FMR2 family member 1
K02211 CDK9; cyclin-dependent kinase 9 [EC:2.7.11.22 2.7.11.23]
K15188 CCNT; cyclin T
K15188 CCNT; cyclin T
K15187 MLLT1_3; YEATS domain-containing protein 1/3
K15187 MLLT1_3; YEATS domain-containing protein 1/3
K11427 DOT1L; [histone H3]-lysine79 N-trimethyltransferase [EC:2.1.1.360]
K15612 LMO2; rhombotin-2
K15610 PBX3; pre-B-cell leukemia transcription factor 3
K09278 RUNX2; runt-related transcription factor 2
K04676 SMAD1; mothers against decapentaplegic homolog 1
K15605 KLF3; krueppel-like factor 3
K04454 MEF2C; MADS-box transcription enhancer factor 2C
K21950 HOXA9; homeobox protein Hox-A9
K17443 HOXA10; homrobox protein Hox-A10
K11449 JMJD1C; jumonji domain-containing protein 1C [EC:1.14.11.-]
K09283 HMGA2; high mobility group AT-hook protein 2
K11447 UTX; lysine-specific demethylase 6A [EC:1.14.11.68]
K11313 SUPT3H; transcription initiation protein SPT3
K06532 PROM1; prominin 1
K05092 FLT3; fms-related tyrosine kinase 3 [EC:2.7.10.1]
K08854 BMP2K; BMP2 inducible kinase [EC:2.7.11.1]
K05087 IGF1R; insulin-like growth factor 1 receptor [EC:2.7.10.1]
K06624 CDKN1B; cyclin-dependent kinase inhibitor 1B
K08821 CDK14; cyclin-dependent kinase 14 [EC:2.7.11.22]
K15613 MEIS1; homeobox protein Meis1
K21951 HOXA11; homeobox protein Hox-A11
K15614 SIX1; homeobox protein SIX1
K15615 SIX4; homeobox protein SIX4
K15616 EYA1; eyes absent homolog 1 [EC:3.1.3.48]
K06622 CDKN2C; cyclin-dependent kinase inhibitor 2C
K00069 HPGD; 15-hydroxyprostaglandin dehydrogenase (NAD) [EC:1.1.1.141]
K05199 GRIA3; glutamate receptor 3
K00717 FUT8; glycoprotein 6-alpha-L-fucosyltransferase [EC:2.4.1.68]
K15607 TLX3; T-cell leukemia homeobox protein 3
K09340 TLX1; T-cell leukemia homeobox protein 1
K22046 BCL11B; B-cell lymphoma/leukemia 11B
K15617 LDB1; LIM domain-binding protein 1
K15604 LYL1; protein lyl-1
K08024 HHEX; homeobox protein HEX
K06056 PTCRA; pre T-cell antigen receptor alpha
K09254 REL; c-Rel proto-oncogene protein
K10151 CCND2; G1/S-specific cyclin-D2
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K16060 BIRC2_3; baculoviral IAP repeat-containing protein 2/3
K03172 TRAF1; TNF receptor-associated factor 1
K04570 BCL2L1; Bcl-2-like 1 (apoptosis regulator Bcl-X)
K05413 CD86; CD86 antigen
K03160 TNFRSF5; tumor necrosis factor receptor superfamily member 5
K15618 BCL6; B-cell lymphoma 6 protein
K06856 IGH; immunoglobulin heavy chain
K09035 CMAF; transcription factor Maf
K06590 ITGB7; integrin beta 7
K11424 WHSC1; [histone H3]-lysine36 N-dimethyltransferase NSD2 [EC:2.1.1.357]
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K11253 H3; histone H3
K09383 PAX5; paired box protein 5
K09293 PAX8; paired box protein 8
K08530 NR1C3; peroxisome proliferator-activated receptor gamma
K08524 RXRA; retinoid X receptor alpha
K08525 RXRB; retinoid X receptor beta
K08526 RXRG; retinoid X receptor gamma
K13105 PRCC; proline-rich protein PRCC
K09105 TFE3; transcription factor E3
K06625 CDKN1A; cyclin-dependent kinase inhibitor 1A
K09633 TMPRSS2; transmembrane protease serine 2 [EC:3.4.21.122]
K09435 ERG; transcriptional regulator ERG
K01348 PLAU; urokinase plasminogen activator [EC:3.4.21.73]
K01343 PLAT; tissue plasminogen activator [EC:3.4.21.68]
K01394 MMP3; matrix metalloproteinase-3 (stromelysin 1, progelatinase) [EC:3.4.24.17]
K01403 MMP9; matrix metalloproteinase-9 (gelatinase B) [EC:3.4.24.35]
K09299 ZEB1; zinc finger homeobox protein 1
K04387 IL1R2; interleukin 1 receptor type II
K15619 SPINT1; Kunitz-type protease inhibitor 1
K09431 ETV1; ets translocation variant 1
K15592 ETV4; ets translocation variant 4
K15593 ETV5; ets translocation variant 5
K15379 SLC45A3; solute carrier family 45, member 3
K04376 ELK4; ETS domain-containing protein Elk-4
K12823 DDX5; ATP-dependent RNA helicase DDX5/DBP2 [EC:5.6.2.7]
K09109 NMYC; N-myc proto-oncogene protein
K04453 MAX; Max protein
K06643 MDM2; E3 ubiquitin-protein ligase Mdm2 [EC:2.3.2.27]
K05725 PTK2; focal adhesion kinase 1 [EC:2.7.10.2]
K04451 TP53; tumor protein p53
K11459 PCGF4; polycomb group RING finger protein 4
K11459 PCGF4; polycomb group RING finger protein 4
K04684 SP1; transcription factor Sp1
K10500 ZBTB17; zinc finger and BTB domain-containing protein 17
K03176 NTRK1; neurotrophic tyrosine kinase receptor type 1 [EC:2.7.10.1]
K02583 NGFR; tumor necrosis factor receptor superfamily member 16
K14970 MEN1; menin
K13209 EWSR1; RNA-binding protein EWS
K09436 FLI1; friend leukemia integration 1 transcription factor
K05459 IGF1; insulin-like growth factor 1
K17693 ID2; DNA-binding protein inhibitor ID2
K04388 TGFBR2; TGF-beta receptor type-2 [EC:2.7.11.30]
K10138 IGFBP3; insulin-like growth factor-binding protein 3
K09437 FEV; ETS oncogene family protein FEV
K09053 ATF1; activating transcription factor 1
K15589 ARNT2; aryl hydrocarbon receptor nuclear translocator 2
K04728 ATM; serine-protein kinase ATM [EC:2.7.11.1]
K09455 MITF; microphthalmia-associated transcription factor
K09234 WT1; Wilms tumor protein 1
K04359 PDGFA; platelet-derived growth factor subunit A
K05069 IL2RB; interleukin 2 receptor beta
K15621 BAIAP3; BAI1-associated protein 3
K06571 TSPAN7; tetraspanin-7
K15622 MLF1; myeloid leukemia factor 1
K08559 NR4A3; nuclear receptor subfamily 4 group A member 3
K14651 TAF15; transcription initiation factor TFIID subunit 15
K13098 TLS; RNA-binding protein FUS
K04452 DDIT3; DNA damage-inducible transcript 3
K10048 CEBPB; CCAAT/enhancer binding protein (C/EBP), beta
K05405 IL6; interleukin 6
K14242 NFKBIZ; NF-kappa-B inhibitor zeta
K02580 NFKB1; nuclear factor NF-kappa-B p105 subunit
K04735 RELA; transcription factor p65
K10030 IL8; interleukin 8
K09381 PAX3_7; paired box protein 3/7
K09381 PAX3_7; paired box protein 3/7
K07201 FOXO1; forkhead box protein O1
K05096 FLT1; FMS-like tyrosine kinase 1 [EC:2.7.10.1]
K15623 SS18; protein SSXT
K15623 SS18; protein SSXT
K15624 SSX1; protein SSX1
K15625 SSX2; protein SSX2
K15625 SSX2; protein SSX2
K15626 NUPR1; nuclear protein 1
K15627 ASPSCR1; tether containing UBX domain for GLUT4
K05099 MET; proto-oncogene tyrosine-protein kinase Met [EC:2.7.10.1]
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K04402 GADD45; growth arrest and DNA-damage-inducible protein
K02159 BAX; apoptosis regulator BAX
K14021 BAK; Bcl-2 homologous antagonist/killer
K10140 DDB2; DNA damage-binding protein 2
K03511 POLK; DNA polymerase kappa [EC:2.7.7.7]
|
05206 MicroRNAs in cancer [PATH:hsa05206]
|
05205 Proteoglycans in cancer [PATH:hsa05205]
|
05204 Chemical carcinogenesis - DNA adducts [PATH:hsa05204]
|
05207 Chemical carcinogenesis - receptor activation [PATH:hsa05207]
|
05208 Chemical carcinogenesis - reactive oxygen species [PATH:hsa05208]
|
05203 Viral carcinogenesis [PATH:hsa05203]
|
05230 Central carbon metabolism in cancer [PATH:hsa05230]
|
05231 Choline metabolism in cancer [PATH:hsa05231]
|
05235 PD-L1 expression and PD-1 checkpoint pathway in cancer [PATH:hsa05235]
|
|
|
09162 Cancer: specific types
|
|
|
09172 Infectious disease: viral
|
|
|
09171 Infectious disease: bacterial
|
05110 Vibrio cholerae infection [PATH:hsa05110]
|
05120 Epithelial cell signaling in Helicobacter pylori infection [PATH:hsa05120]
|
05130 Pathogenic Escherichia coli infection [PATH:hsa05130]
|
05132 Salmonella infection [PATH:hsa05132]
|
05131 Shigellosis [PATH:hsa05131]
|
05135 Yersinia infection [PATH:hsa05135]
|
05133 Pertussis [PATH:hsa05133]
|
05134 Legionellosis [PATH:hsa05134]
|
05150 Staphylococcus aureus infection [PATH:hsa05150]
|
3857 KRT9; keratin 9
3858 KRT10; keratin 10
3859 KRT12; keratin 12
3860 KRT13; keratin 13
3861 KRT14; keratin 14
3866 KRT15; keratin 15
3868 KRT16; keratin 16
3872 KRT17; keratin 17
3875 KRT18; keratin 18
3880 KRT19; keratin 19
3881 KRT31; keratin 31
3882 KRT32; keratin 32
3883 KRT33A; keratin 33A
3884 KRT33B; keratin 33B
3885 KRT34; keratin 34
3886 KRT35; keratin 35
125115 KRT40; keratin 40
390792 KRT39; keratin 39
25984 KRT23; keratin 23
147183 KRT25; keratin 25
162605 KRT28; keratin 28
192666 KRT24; keratin 24
342574 KRT27; keratin 27
54474 KRT20; keratin 20
8687 KRT38; keratin 38
8688 KRT37; keratin 37
8689 KRT36; keratin 36
100653049 keratin, type I cuticular Ha4
353288 KRT26; keratin 26
2266 FGG; fibrinogen gamma chain
718 C3; complement C3
629 CFB; complement factor B
1675 CFD; complement factor D
3075 CFH; complement factor H
4153 MBL2; mannose binding lectin 2
5648 MASP1; MBL associated serine protease 1
10747 MASP2; MBL associated serine protease 2
102723407 IGH; immunoglobulin heavy variable 4-38-2-like
712 C1QA; complement C1q A chain
713 C1QB; complement C1q B chain
714 C1QC; complement C1q C chain
715 C1R; complement C1r
716 C1S; complement C1s
717 C2; complement C2
720 C4A; complement C4A (Chido/Rodgers blood group)
721 C4B; complement C4B (Chido/Rodgers blood group)
727 C5; complement C5
719 C3AR1; complement C3a receptor 1
728 C5AR1; complement C5a receptor 1
2209 FCGR1A; Fc gamma receptor Ia
2212 FCGR2A; Fc gamma receptor IIa
2213 FCGR2B; Fc gamma receptor IIb
9103 FCGR2C; Fc gamma receptor IIc (gene/pseudogene)
2214 FCGR3A; Fc gamma receptor IIIa
2215 FCGR3B; Fc gamma receptor IIIb
2204 FCAR; Fc alpha receptor
2359 FPR3; formyl peptide receptor 3
2358 FPR2; formyl peptide receptor 2
2357 FPR1; formyl peptide receptor 1
5340 PLG; plasminogen
3426 CFI; complement factor I
6404 SELPLG; selectin P ligand
6403 SELP; selectin P
3383 ICAM1; intercellular adhesion molecule 1
3683 ITGAL; integrin subunit alpha L
3684 ITGAM; integrin subunit alpha M
3689 ITGB2; integrin subunit beta 2
1672 DEFB1; defensin beta 1
1673 DEFB4A; defensin beta 4A
100289462 DEFB4B; defensin beta 4B
414325 DEFB103A; defensin beta 103A
55894 DEFB103B; defensin beta 103B
1667 DEFA1; defensin alpha 1
1668 DEFA3; defensin alpha 3
1669 DEFA4; defensin alpha 4
1670 DEFA5; defensin alpha 5
1671 DEFA6; defensin alpha 6
728358 DEFA1B; defensin alpha 1B
820 CAMP; cathelicidin antimicrobial peptide
1828 DSG1; desmoglein 1
3108 HLA-DMA; major histocompatibility complex, class II, DM alpha
3109 HLA-DMB; major histocompatibility complex, class II, DM beta
3111 HLA-DOA; major histocompatibility complex, class II, DO alpha
3112 HLA-DOB; major histocompatibility complex, class II, DO beta
3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1
3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1
3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1
3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2
3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1
3122 HLA-DRA; major histocompatibility complex, class II, DR alpha
3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1
3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3
3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4
3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5
5724 PTAFR; platelet activating factor receptor
3586 IL10; interleukin 10
|
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K07604 KRT1; type I keratin, acidic
K03905 FGG; fibrinogen gamma chain
K03990 C3; complement component 3
K01335 CFB; complement factor B [EC:3.4.21.47]
K01334 CFD; complement factor D [EC:3.4.21.46]
K04004 CFH; complement factor H
K03991 MBL; mannose-binding lectin
K03992 MASP1; mannan-binding lectin serine protease 1 [EC:3.4.21.-]
K03993 MASP2; mannan-binding lectin serine protease 2 [EC:3.4.21.104]
K06856 IGH; immunoglobulin heavy chain
K03986 C1QA; complement C1q subcomponent subunit A
K03987 C1QB; complement C1q subcomponent subunit B
K03988 C1QG; complement C1q subcomponent subunit C
K01330 C1R; complement component 1, r subcomponent [EC:3.4.21.41]
K01331 C1S; complement component 1, s subcomponent [EC:3.4.21.42]
K01332 C2; complement component 2 [EC:3.4.21.43]
K03989 C4; complement component 4
K03989 C4; complement component 4
K03994 C5; complement component 5
K04009 C3AR1; C3a anaphylatoxin chemotactic receptor
K04010 C5AR1; C5a anaphylatoxin chemotactic receptor 1
K06498 FCGR1A; high affinity immunoglobulin gamma Fc receptor I
K06472 FCGR2A; low affinity immunoglobulin gamma Fc receptor II-a
K12560 FCGR2B; low affinity immunoglobulin gamma Fc receptor II-b
K16824 FCGR2C; low affinity immunoglobulin gamma Fc receptor II-c
K06463 FCGR3; low affinity immunoglobulin gamma Fc receptor III
K06463 FCGR3; low affinity immunoglobulin gamma Fc receptor III
K06513 FCAR; CD89 antigen
K04173 FPRL; formyl peptide receptor-like
K04173 FPRL; formyl peptide receptor-like
K04172 FPR1; formyl peptide receptor 1
K01315 PLG; plasminogen [EC:3.4.21.7]
K01333 CFI; complement factor I [EC:3.4.21.45]
K06544 SELPLG; selectin P ligand
K06496 SELP; selectin, platelet
K06490 ICAM1; intercellular adhesion molecule 1
K05718 ITGAL; integrin alpha L
K06461 ITGAM; integrin alpha M
K06464 ITGB2; integrin beta 2
K23125 DEFB1; beta-defensin 1
K21100 DEFB4; beta-defensin 4
K21100 DEFB4; beta-defensin 4
K23126 DEFB103; beta-defensin 103
K23126 DEFB103; beta-defensin 103
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K05230 DEFA; defensin, alpha
K13916 CAMP; cathelicidin antimicrobial peptide
K07596 DSG1; desmoglein 1
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K06752 MHC2; MHC class II antigen
K04279 PTAFR; platelet-activating factor receptor
K05443 IL10; interleukin 10
|
05152 Tuberculosis [PATH:hsa05152]
|
05100 Bacterial invasion of epithelial cells [PATH:hsa05100]
|
|
|
09174 Infectious disease: parasitic
|
|
|
09163 Immune disease
|
|
|
09164 Neurodegenerative disease
|
|
|
09165 Substance dependence
|
|
|
09166 Cardiovascular disease
|
|
|
09167 Endocrine and metabolic disease
|
|
|
09175 Drug resistance: antimicrobial
|
|
|
09176 Drug resistance: antineoplastic
|
|
|
09180 Brite Hierarchies
|
|
|
09190 Not Included in Pathway or Brite
|